Inventor
CHANG TSE WEN
US66 patents
⚠️ This page may combine multiple inventors who share the name “CHANG TSE WEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TANOX BIOSYSTEMS INC
20 patentsUS5723125AMar 3, 1998
Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
TANOX BIOSYSTEMS INC335 citations99
US5091313AFeb 25, 1992
Antigenic epitopes of IgE present on B cell but not basophil surface
TANOX BIOSYSTEMS INC201 citations99
US5872222AFeb 16, 1999
Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
TANOX BIOSYSTEMS INC60 citations96
US5866129AFeb 2, 1999
Method of producing an antibody with a peptide corresponding to membrane-bound IgA
TANOX BIOSYSTEMS INC73 citations96
US5670626ASep 23, 1997
Allergen-specific human IgA monoclonal antibodies for mucosal administration
TANOX BIOSYSTEMS INC54 citations96
US5449760ASep 12, 1995
Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
TANOX BIOSYSTEMS INC51 citations96
US5428133AJun 27, 1995
Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils
TANOX BIOSYSTEMS INC71 citations96
US5422258AJun 6, 1995
Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
TANOX BIOSYSTEMS INC54 citations96
US5231026AJul 27, 1993
DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE
TANOX BIOSYSTEMS INC54 citations96
US5342924AAug 30, 1994
Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor
TANOX BIOSYSTEMS INC87 citations94
US5514776AMay 7, 1996
Peptides representing antigenic epitopes of dog IgE present on B cell but not basophil surface
TANOX BIOSYSTEMS INC26 citations93
US5274075ADec 28, 1993
Newly identified human epsilon immunoglobulin peptides and related products
TANOX BIOSYSTEMS INC36 citations93
US5260416ANov 9, 1993
Antigenic epitopes present on membrane-bound but not secreted IgE
TANOX BIOSYSTEMS INC33 citations93
US5252467AOct 12, 1993
Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
TANOX BIOSYSTEMS INC33 citations93
US5690934ANov 25, 1997
Peptides relating to the extracellular membrane-bound segment of human alpha chain
TANOX BIOSYSTEMS INC25 citations92
US5089603AFeb 18, 1992
Antigenic epitopes present on membrane-bound but not secreted iga
TANOX BIOSYSTEMS INC26 citations92
US5149782ASep 22, 1992
Molecular conjugates containing cell membrane-blending agents
TANOX BIOSYSTEMS INC128 citations91
US5834599ANov 10, 1998
Immunoconjugates which neutralize HIV-1 infection
TANOX BIOSYSTEMS INC33 citations89
US5420251AMay 30, 1995
Anti-idiotype antibodies specific for the parotope of antibodies which bind to IgE-bearing B cells but not basophils
TANOX BIOSYSTEMS INC34 citations89
US5079344AJan 7, 1992
Antigenic epitopes present on membrane-bound but not secreted IgA
TANOX BIOSYSTEMS INC26 citations86
IMMUNWORK INC
12 patentsUS10010626B2Jul 3, 2018
Molecular constructs with targeting and effector moieties
IMMUNWORK INC7 citations84
US9623118B2Apr 18, 2017
Multi-arm linker constructs for treating pathological blood clots
IMMUNWORK INC5 citations84
US9975951B2May 22, 2018
Peptide core-based multi-arm linkers and their applications
IMMUNWORK INC3 citations72
US9907858B2Mar 6, 2018
Peptide core-based multi-arm linkers
IMMUNWORK INC3 citations72
US11235064B2Feb 1, 2022
Core constructs and their uses in configuring pharmaceutical molecules
IMMUNWORK INC0 citations62
US10894091B2Jan 19, 2021
Linker units and molecular constructs comprising the same
IMMUNWORK INC1 citations62
US9994638B2Jun 12, 2018
Peptide core-based multi-arm linkers for treating infectious diseases
IMMUNWORK INC1 citations62
US9988454B2Jun 5, 2018
Peptide core-based multi-arm linkers for treating central nervous system diseases
IMMUNWORK INC1 citations62
US9688776B2Jun 27, 2017
Anti-human mIgA antibodies capable of lysing mIgA-B lymphocytes and decreasing IgA production
IMMUNWORK INC2 citations61
US11220680B2Jan 11, 2022
Polypeptide for treating pathological blood clots
IMMUNWORK INC0 citations60
US11926678B2Mar 12, 2024
Composite polypeptide having a metal binding motif and molecular construct comprising the same
IMMUNWORK INC0 citations56
US11203614B2Dec 21, 2021
Composite polypeptide having a metal binding motif and molecular construct comprising the same
IMMUNWORK INC0 citations56
TANOX INC
10 patentsUS5908626AJun 1, 1999
Hybrid with interferon-β and an immunoglobulin Fc joined by a peptide linker
TANOX INC275 citations99
US6197298B1Mar 6, 2001
Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
TANOX INC57 citations96
US6129916AOct 10, 2000
Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
TANOX INC79 citations96
US6117982ASep 12, 2000
Conjugates of microbeads and antibodies specific for T lymphocytes and their use as in vivo immune modulators
TANOX INC32 citations93
US6106835AAug 22, 2000
Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
TANOX INC22 citations93
US6309880B1Oct 30, 2001
Antibodies specific for CD4-binding domain of HIV-1
TANOX INC18 citations92
US5981278ANov 9, 1999
Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
TANOX INC20 citations92
US5854400ADec 29, 1998
Monoclonal antibodies which neutralize HIV-1 infection
TANOX INC36 citations92
US6657050B1Dec 2, 2003
Chimeric viral-neutralizing immunoglobulins
TANOX INC11 citations74
US6685930B1Feb 3, 2004
Methods and substances for recruiting therapeutic agents to solid tumors
TANOX INC3 citations63
ACADEMIA SINICA
3 patentsUS9718891B2Aug 1, 2017
Antibodies specific to a novel epitope on CεMX of human membrane-bound IgE and uses thereof in treating IgE-mediated diseases
ACADEMIA SINICA4 citations67
US10047166B2Aug 14, 2018
Humanized anti-IgE antibodies that crosslink CD23 on B lymphocytes but do not sensitize mast cells
ACADEMIA SINICA2 citations66
US8974794B2Mar 10, 2015
C(epsilon)mX peptides for inducing immune responses to human mIgE on B lymphocytes
ACADEMIA SINICA3 citations59
CENTOCOR INC
2 patentsSILICONWARE PRECISION INDUSTRIES CO LTD
1 patentCHICONY POWER TECH CO LTD
1 patentHUNG SHUEN-IU
1 patentShowing the top 50 of 66 patents by PatentIndex Score.